MARIAH HAMILTON: Open Payments
NPI 1437850997 · MARIETTA, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$909 in 41 payments from 13 companies in 2025. Trend: 2023 $72 · 2024 $880 · 2025 $909
Food & beverage: $909
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 11 | $219 |
| Novartis Pharmaceuticals Corporation | 4 | $113 |
| Amgen Inc. | 5 | $109 |
| UCB, Inc. | 4 | $91 |
| E.R. Squibb & Sons, L.L.C. | 4 | $81 |
| GlaxoSmithKline, LLC. | 3 | $57 |
| Janssen Biotech, Inc. | 2 | $50 |
| AstraZeneca Pharmaceuticals LP | 2 | $49 |
| Fresenius Kabi USA, LLC | 2 | $47 |
| Aurinia Pharma U.S., Inc. | 1 | $28 |
Products named: RINVOQ, COSENTYX, OTEZLA, SKYRIZI, Bimzelx, ORENCIA, BENLYSTA, TREMFYA.
Industry payments across GA — which companies pay providers there.
